Article Information
History
- March 24, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Amol Carl Shetty1,
- John Sivinski2,
- Jessica Cornell2,
- Lisa Sadzewicz1,
- Anup Mahurkar1,
- Xing-Qun Wang3,
- Luana Colloca4,
- Weihong Lin5,
- Maureen A. Kane6 and
- Chamindi Seneviratne1,2,*
- 1Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA
- 2Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA
- 3University of Virginia, Departments of Public Health Sciences, Charlottesville, VA, USA
- 4Dept of Pain and Translational Symptom Science | Placebo Beyond Opinions (PBO) Center, University of Maryland School of Nursing, Baltimore, MD, USA
- 5Departmnt of Biological Sciences, University of Maryland, Baltimore County, Baltimore, MD, USA
- 6Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD, USA
- ↵*Correspondence: Chamindi Seneviratne, MD, 670 W. Baltimore Street, Institute for Genome Sciences, HSF3, Baltimore, Maryland, MD21201, csenevi{at}som.umaryland.edu
Posted March 24, 2023.
Peripheral blood transcriptomic profiling indicates molecular mechanisms commonly regulated by binge-drinking and placebo-effects
